Lichen Planus, Oral
15
1
2
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
0%
0 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (15)
Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus
Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study
The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus
Evaluation of Desmoglein-3 Autoantibodies in the Tissues of Oral Lichen Planus and Correlation with Disease Severity
Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
Comparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen Planus
Study on Treatment for Patients With Symptomatic Oral Lichen Planus
Treatment Protocols for Patients With Symptomatic Oral Lichen Planus
Lichen Planus and Mean Platelet Volum
Photobiomodulation in Oral Lichen Planus
Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus
Efficacy of Purslane in Treatment of Oral Lichen Planus
Efficacy of Elidel Cream on Erosive Oral Lichen Planus
Treatmant of Oral Lichen Planus With Lycopene
Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus